Zobrazeno 1 - 10
of 942
pro vyhledávání: '"Weinreb N"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Alfonso González-Ortega, Mónica Segovia Pérez, Rodrigo Navarro, Maria Carmen Sanudo, Luis Calvo
Publikováno v:
ChemInform. 37
Pyrroles fused to diverse carbocycles and heterocycles were prepared from Weinreb N-vinyl-a-amino carboxamides inte- grated in cyclic systems. The selective reaction of the carboxamide group with organometallic compounds allowed us to obtain a great
Autor:
Calvo, Luis
Publikováno v:
Synthesis; November 2002, Vol. 2002 Issue: 16 p2450-2456, 7p
Publikováno v:
ChemInform. 34
Weinreb 3-(pyrrolidin-2-ylidene)propionamides and Weinreh N-vinylprolinamides were used for the synthesis of 2,3-di-hydropyrrolizines. The selective reaction of the carboxamide group with organometallic compounds allowed us to obtain a great variety
Autor:
Luis Calvo
Publikováno v:
Synthesis; Nov2005, Vol. 2005 Issue 18, p3152-3158, 7p
Publikováno v:
ChemInform; March 2006, Vol. 37 Issue: 13 pno-no
Publikováno v:
ChemInform; February 2003, Vol. 34 Issue: 8 pno-no
Autor:
Elstein D; Takeda Pharmaceuticals International AG, Zurich, Switzerland. debby.elstein@gmail.com., Belmatoug N; Assistance-Publique Hôpitaux de Paris Nord, Université de Paris, Paris, France., Deegan P; Lysosomal Disorders Unit, Cambridge University Hospitals, Cambridge, UK., Göker-Alpan Ö; Lysosomal Disorders Unit and Center for Clinical Trials, O&O Alpan LLC, Fairfax, VA, USA., Hughes DA; Royal Free London NHS Foundation Trust, London, UK., Schwartz IVD; Medical Genetics Service - HCPA, Genetics Department, UFRGS, Porte Alegre, Brazil., Weinreb N; University of Miami Miller School of Medicine, Miami, FL, USA., Bonner N; Adelphi Values, Bollington, UK., Panter C; Adelphi Values, Bollington, UK., Fountain D; PHMR, London, UK., Lenny A; PHMR, London, UK., Longworth L; PHMR, London, UK., Miller R; PHMR, London, UK., Shah K; PHMR, London, UK., Schenk J; Takeda Pharmaceuticals International AG, Zurich, Switzerland., Sen R; Takeda Pharmaceuticals Company Ltd, Cambridge, MA, USA., Zimran A; Gaucher Unit, Shaare Zedek Medical Center, Jerusalem, Israel.; Hebrew University-Hadassah Medical School, Jerusalem, Israel.
Publikováno v:
Orphanet journal of rare diseases [Orphanet J Rare Dis] 2022 Jan 06; Vol. 17 (1), pp. 9. Date of Electronic Publication: 2022 Jan 06.
Autor:
Deegan P; Lysosomal Disorders Unit, Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust, Hills Road, Box 135, Cambridge, CB2 0QQ, UK. patrick.deegan@addenbrookes.nhs.uk., Khan A; Department of Medical Genetics and Pediatrics, Alberta Children's Hospital Research Institute, Cumming School of Medicine, University of Calgary, Calgary, Canada., Camelo JS Jr; Department of Pediatrics, Ribeirão Preto Medical School, University of São Paulo, São Paulo, Brazil., Batista JL; Sanofi Genzyme, Cambridge, MA, USA., Weinreb N; Departments of Human Genetics and Medicine (Hematology), University of Miami Miller School of Medicine, Miami, FL, USA.
Publikováno v:
Orphanet journal of rare diseases [Orphanet J Rare Dis] 2021 Feb 18; Vol. 16 (1), pp. 92. Date of Electronic Publication: 2021 Feb 18.